Starling Oncology (STLNW) Net Margin Growth (1y) (2022 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Net Margin Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | 151.00 |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | -138.00 |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | -21.00 |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | 272.00 |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | 92.00 |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | -21.00 |
| 7 | Progyny | 2.12 Bn | 1.89 Bn | 89.30 Mn | 286.00 |
| 8 | Surgery Partners | 1.82 Bn | 1.61 Bn | 622.10 Mn | -194.00 |
| 9 | U S Physical Therapy | 1.17 Bn | 1.14 Bn | 41.94 Mn | -202.00 |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 657.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 657.00 |
| Mar 31, 2026 | 1,398.00 |
| Dec 31, 2025 | 627.00 |
| Sep 30, 2025 | 315.00 |
| Jun 30, 2025 | 118.00 |
| Mar 31, 2025 | 561.00 |
| Dec 31, 2024 | 1,106.00 |
| Sep 30, 2024 | 800.00 |
| Jun 30, 2024 | 820.00 |
| Mar 31, 2024 | 1,836.00 |
| Dec 31, 2023 | -645.00 |
| Sep 30, 2023 | -1,712.00 |
| Jun 30, 2023 | -1,211.00 |
| Mar 31, 2023 | -7,433.00 |
| Dec 31, 2022 | 358.00 |
| Sep 30, 2022 | -345.00 |
| Jun 30, 2022 | 333.00 |
| Mar 31, 2022 | 2,323.00 |